Pharmacoflash / Posters Modérés (PM2) - STP 2

• 32 • PM2-008 - State of the art of unbound ceftriaxone as a pharmacodynamic tool: are we ready for its implementation in clinical practice? > T. Thomas DUFLOT • 54 • PM2-009 - Modelling the population pharmacokinetics of heparin in patients undergoing radiofrequency ablation of atrial fibrillation and nomogram to target activated clotting time. > C. Celine Konecki • 99 • PM2-010 - What clindamycin dose for which administration route in case of combination with rifampicin? > S. Sophie Magreault • 193 • PM2-011 - Exploring the feasibility of dried blood spot (DBS) sampling for caffeine exposure analysis in microgravity during parabolic flights > A. Audrey Derobertmasure • 227 • PM2-012 - Non invasive radiotracers pharmacokinetics extraction by deep learning > T. Théodore Soulier • 256 • PM2-013 - Pharmacokinetics of rifampicin and its metabolite 25-deacetylrifampicin in patients with tuberculosis : evidence of auto-induction of both agents > S. Sylvain Goutelle • 302 • PM2-014 - Elexacaftor/tezacaftor/ivacaftor population pharmacokinetics in paediatric patients with cystic fibrosis > N. Ngoc Hoa Truong